Association of serum caffeine concentrations with blood lipids in caffeine-drug users and nonusers - Results of German National Health Surveys from 1984 to 1999

European Journal of Epidemiology

Volumn 20, Issue 4, 2005, Pages 311-316

  Du, Yong ^a,b   Melchert, Hans Ulrich ^a   Knopf, Hildtraud ^a   Braemer Hauth, Marianne ^a   Gerding, Barbara ^a   Pabel, Ellen ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b FUDAN UNIVERSITY   (China)

Author keywords

Blood lipids; Caffeine; Germany; National health survey

Indexed keywords

CAFFEINE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; LIPID BLOOD LEVEL; MALE; NORMAL HUMAN; PATHOGENESIS; REGRESSION ANALYSIS; REVIEW;

ADOLESCENT; ADULT; AGED; CAFFEINE; FEMALE; GERMANY; HEALTH SURVEYS; HUMANS; IMMUNOENZYME TECHNIQUES; LIPIDS; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; POPULATION SURVEILLANCE;

EID: 18844431130     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10654-004-7536-x     Document Type: Review

References (38)

1. BB Fredholm K Battig J Holmen A Nehlig EE. Zvartau 1999 Actions of caffeine in the brain with special reference to factors that contribute to its widespread use Pharmacol Rev 51 83 133
2. PW Wilson RJ Garrison WB Kannel DL McGee WP. Castelli 1989 Is coffee consumption a contributor to cardiovascular disease? Insights from the Framingham study. Arch Intern Med 149 1169 1172
3. TM Chou NL. Benowitz 1994 Caffeine and coffee: effects on health and cardiovascular disease Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 109 173 189
4. A Tverdal T Stensvold K Solvoll OP Foss P Lund-Larsen K. Bjartveit 1990 Coffee consumption and death from coronary heart disease in middle aged Norwegian men and women BMJ 300 566 569
5. DE Grobbee EB Rimm E Giovannucci G Colditz M Stampfer W. Willett 1990 Coffee, caffeine, and cardiovascular disease in men N Engl J Med 323 1026 1032
6. SH Jee J He LJ Appel PK Whelton I Suh MJ. Klag 2001 Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials Am J Epidemiol 153 353 362
7. BR Davis JD Curb NO Borhani RJ Prineas A. Molteni 1988 Coffee consumption and serum cholesterol in the hypertension detection and follow-up program Am J Epidemiol 128 124 136
8. K Kokjohn M Graham M. McGregor 1993 The effect of coffee consumption on serum cholesterol levels J Manipulative Physiol Ther 16 327 335
9. R Urgert T van Vliet PL Zock MB. Katan 2000 Heavy coffee consumption and plasma homocysteine: a randomized controlled trial in healthy volunteers Am J Clin Nutr 72 1107 1110
10. MR Olthof PC Hollman PL Zock MB. Katan 2001 Consumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentration in humans Am J Clin Nutr 73 532 538
11. J van Rooij GH van der Stegen RC Schoemaker 1995 A placebo-controlled parallel study of the effect of two types of coffee oil on serum lipids and transaminases: identification of chemical substances involved in the cholesterol-raising effect of coffee Am J Clin Nutr 61 1277 1283
12. MP Weusten-Vander Wouw MB Katan R Viani 1994 Identity of the cholesterol-raising factor from boiled coffee and its effects on liver function enzymes J Lipid Res 35 721 733
13. B Christensen A Mosdol L Retterstol S Landaas DS. Thelle 2001 Abstention from filtered coffee reduces the concentrations of plasma homocysteine and serum cholesterol - a randomized controlled trial Am J Clin Nutr 74 302 307
14. R Urgert S Meyboom M Kuilman 1996 Comparison of effect of cafetiere and filtered coffee on serum concentrations of liver aminotransferases and lipids: six month randomised controlled trial BMJ 313 1362 1366
15. A D'Amicis C Scaccini G Tomassi M Anaclerio R Stornelli A. Bernini 1996 Italian style brewed coffee: effect on serum cholesterol in young men Int J Epidemiol 25 513 520
16. GCP Study Group. 1988 The German Cardiovascular Prevention Study (GCP): design and methods. GCP Study Group Eur Heart J 9 1058 1066
17. HU Melchert B Görsch H. Hoffmeister 1995 Nichtstationäre Arzneimittelanwendung und subjektive Arzneimittelverträglichkeit in der bundesdeutschen Wohnbevölkerung der 25- bis 69jährigen: zur Epidemiologie des Arzneimittelkonsums und der unerwünschten Arzneimittelwirkungen; Ergebnisse der Erhebung des ersten Nationalen Untersuchungs-Surveys 1984-1986 MMV Medizin Verlag München
18. H Hoffmeister H Hüttner H Stolzenberg H Lopez J. Winkler 1992 Sozialer Status und Gesundheit: Nationaler Gesundheits-Surveys 1984-1986 MMV Medizin Verlag München
19. H Knopf HU. Melchert 2003 Bundes-Gesundheitssurvey: Arzneimittelgebrauch Robert Koch-Institut Berlin
20. WT Friedewald RI Levy DS. Fredrickson 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 499 502
21. CA Carson JA Cauley AW. Caggiula 1993 Relation of caffeine intake to blood lipids in elderly women Am J Epidemiol 138 94 100
22. FA Sedor KA Schneider S. Heyden 1991 Effect of coffee on cholesterol and apolipoproteins, corroborated by caffeine levels Am J Prev Med 7 391 396
23. AA Bak DE. Grobbee 1991 Caffeine, blood pressure, and serum lipids Am J Clin Nutr 53 971 975
24. J Tuomilehto A Tanskanen P Pietinen 1987 Coffee consumption is correlated with serum cholesterol in middle-aged Finnish men and women J Epidemiol Community Health 41 237 242
25. M van Dusseldorp MB Katan T van Vliet PN Demacker AF. Stalenhoef 1991 Cholesterol-raising factor from boiled coffee does not pass a paper filter Arterioscler Thromb 11 586 593
26. A Aro J Teirila CG. Gref 1990 Dose-dependent effect on serum cholesterol and apoprotein B concentrations by consumption of boiled, non-filtered coffee Atherosclerosis 83 257 261
27. M van Dusseldorp MB Katan PN. Demacker 1990 Effect of decaffeinated versus regular coffee on serum lipoproteins. A 12 week double-blind trial Am J Epidemiol 132 33 40
28. HR Superko PT BortzW Williams Jr. JJ Albers PD. Wood 1991 Caffeinated and decaffeinated coffee effects on plasma lipoprotein cholesterol, apolipoproteins, and lipase activity: a controlled, randomized trial Am J Clin Nutr 54 599 605
29. Jacobson KA, von Lubitz DK, Daly JW, Fredholm BB. (2003) Adenosine receptor ligands: differences with acute versus chronic treatment. Trends Pharmacol Sci
30. M Johnson-Kozlow D Kritz-Silverstein E Barrett-Connor D. Morton 2002 Coffee consumption and cognitive function among older adults Am J Epidemiol 156 842 850
31. E Bona U Aden BB Fredholm H. Hagberg 1995 The effect of long term caffeine reatment on hypoxic-ischemic brain damage in the neonate Pediatr Res 38 312 318
32. KA Rudolphi M Keil J Fastbom BB. Fredholm 1989 Ischaemic damage in gerbil hippocampus is reduced following upregulation of adenosine (A1) receptors by caffeine treatment Neurosci Lett 103 275 280
33. A Rosengren A Dotevall L Wilhelmsen D Thelle S. Johansson 2004 Coffee and incidence of diabetes in Swedish women: a prospective 18-year follow-up study J Intern Med 255 89 95
34. EE Agardh S Carlsson A Ahlbom 2004 Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women J Intern Med 255 645 652
35. J Tuomilehto G Hu S Bidel J Lindstrom P. Jousilahti 2004 Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women JAMA 291 1213 1219
36. GW Ross RD Abbott H Petrovitch 2000 Association of coffee and caffeine intake with the risk of Parkinson disease JAMA 283 2674 2679
37. A Ascherio SM Zhang MA Hernan 2001 Prospective study of caffeine consumption and risk of Parkinson's disease in men and women Ann Neurol 50 56 63
38. TR Mikuls JR Cerhan LA Criswell 2002 Coffee, tea, and caffeine consumption and risk of rheumatoid arthritis: results from the Iowa Women's Health Study Arthritis Rheum 46 83 91